Page 118 - Total War on PTSD
P. 118
functional improvement including a greater range of motion and a reduction in stiffness and muscle spasm for up to 72 hours with percutaneous electrodes and for up to 24 hours with noninvasive electrodes following a 30-minute treatment. In addition to providing long-lasting efficacy, these signals are significantly more comfortable leading to improved patient treatment compliance.
BioWave is a frequency conduction pain block. This mechanism of action is similar to a chemical anesthetic like Novocain, except Biowave is blocking the pain signal electrically instead of chemically. BioWave’s signal technology is based on the discovery that when two high-frequency signals are added together in the device and then delivered into the body through a single electrode, the signals will pass into deep tissue and affect all polarized tissues, including nerves like pain fibers, tendons, ligaments and muscle tissue. These polarized tissues cause the two high frequency signals to multiply together resulting in an active therapeutic low frequency electrical field focused in approximately a 3.5-inch diameter hemisphere (think of the size of half of a grapefruit) beneath and surrounding each electrode, not across the surface of the skin between the electrodes like TENS. The BioWave active electrical field prevents the transmission of pain signals along these pain fibers, causes a light numbness to form five minutes into the treatment and causes an increase in blood flow in the volume of tissue beneath and surrounding each electrode. The light numbness remains at the treatment site for up to 20 minutes following a 30-minute treatment. Additionally, muscle tissue is held in tension during the treatment, so the treatment feels like a deep smooth pressure sensation.
Because the electrical field blocks the pain signal internally right at the pain nerve, the magnitude of the efficacy is much greater and the length of residual pain relief can last as long as
118 of 1042